Implementation of high-sensitivity cardiac troponin and risk of myocardial infarction or death at 5 years: a stepped-wedge cluster-randomised controlled trial

Back

ESC Professional Premium Access

Implementation of high-sensitivity cardiac troponin and risk of myocardial infarction or death at 5 years: a stepped-wedge cluster-randomised controlled trial

Session: Troponin and other biomarkers in acute coronary syndromes

Topic: Biomarkers

Speaker: Doctor K. Lee (Edinburgh, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Kuan Ken Lee

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Extending the no objective testing rules to patients triaged by the ESC 0/1-hour algorithms

Speaker: Doctor J. Boeddinghaus (Basel, CH)

Cardiac troponin elevation and mortality in takotsubo syndrome: new insights from the international takotsubo (InterTAK) registry

Speaker: Professor B. Stahli (Zurich, CH)

Impact of time from symptom onset on the diagnostic performance of high-sensitivity cardiac troponin for type 1 myocardial infarction

Speaker: Doctor M. Lowry (Edinburgh, GB)

High-sensitivity troponin is a biomarker of medium term mortality in 20,000 consecutive hospital patients undergoing a blood test for any reason

Speaker: Doctor J. Hinton (Bournemouth, GB)

Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial

Speaker: Doctor K. Jering (Boston, US)

Access the full session

Troponin and other biomarkers in acute coronary syndromes

Speakers: Doctor K. Lee, Doctor J. Boeddinghaus, Professor B. Stahli, Doctor M. Lowry, Doctor J. Hinton...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources